Working… Menu

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03376659
Recruitment Status : Active, not recruiting
First Posted : December 18, 2017
Last Update Posted : November 4, 2020
Mayo Clinic
Indiana University
Emory University
National Cancer Institute (NCI)
George Mason University
Thomas Jefferson University
MedImmune LLC
Bavarian Nordic
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2023